13 results
8-K
EX-99.1
GOVX
Geovax Labs Inc
1 Mar 24
GeoVax Reports 2023 Year-End Financial Results
4:09pm
and emphasize the role it will play in protecting immunocompromised patients from greater risk of severe disease, hospitalization and death from SARS-CoV-2
POS AM
GOVX
Geovax Labs Inc
1 Mar 24
Prospectus update (post-effective amendment)
4:04pm
, there is evidence of the high risk of severe morbidity, hospitalization and death resulting from SARS-CoV-2 in hematology patients. The efficacy and safety … vaccine can protect against severe disease and death induced by SARS-CoV-2 infection, regardless of the variant.
Our Cancer Therapy Programs
POS AM
GOVX
Geovax Labs Inc
1 Mar 24
Prospectus update (post-effective amendment)
4:04pm
of the high risk of severe morbidity, hospitalization and death resulting from SARS-CoV-2 in hematology patients. The efficacy and safety of a SARS … protect against severe disease and death induced by SARS-CoV-2 infection, regardless of the variant.
Our Cancer Therapy Programs
Gedeptin®
POS AM
GOVX
Geovax Labs Inc
1 Mar 24
Prospectus update (post-effective amendment)
4:03pm
, hospitalization and death resulting from SARS-CoV-2 in hematology patients. The efficacy and safety of a SARS-CoV-2 vaccine remains to be established … and death induced by SARS-CoV-2 infection, regardless of the variant.
Our Cancer Therapy Programs
Gedeptin® – Gedeptin is a novel patented product
POS AM
GOVX
Geovax Labs Inc
1 Mar 24
Prospectus update (post-effective amendment)
4:03pm
morbidity and survival. Increasingly, there is evidence of the high risk of severe morbidity, hospitalization and death resulting from SARS-CoV-2 … with the multi-antigen MVA-vectored vaccine can protect against severe disease and death induced by SARS-CoV-2 infection, regardless of the variant
424B3
nzkkkz3f2rbior5u62
12 Jan 24
Prospectus supplement
4:00pm
S-8
EX-99.2
kwm2s7x7
22 Aug 23
Registration of securities for employees
4:06pm
8-K
EX-99.1
o1alj4p48lwk
10 Aug 23
GeoVax Reports 2023 Second Quarter Financial Results
9:45am
8-K
EX-99.1
08237hmq1h4o8d76fj
5 May 23
GeoVax Reports 2023 First Quarter Financial Results
8:48am
- Prev
- 1
- Next